Effects of clonidine and tricyclic antidepressants on gastric smooth muscle contractility

Neurogastroenterology and Motility

Volumn 16, Issue 2, 2004, Pages 143-153

  James, A N ^a   Ryan, J P ^a   Parkman, H P ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alpha adrenergic receptor agonists; Gastric contractility; Tricyclic antidepressants

Indexed keywords

4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; ACETYLCHOLINE; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMITRIPTYLINE; ATROPINE; BRIMONIDINE; CHOLINERGIC RECEPTOR; CITALOPRAM; CLONIDINE; DESIPRAMINE; DOXEPIN; IMIPRAMINE; METHOCTRAMINE; MUSCARINIC M1 RECEPTOR ANTAGONIST; MUSCARINIC M2 RECEPTOR ANTAGONIST; MUSCARINIC M3 RECEPTOR ANTAGONIST; MUSCARINIC RECEPTOR BLOCKING AGENT; N(G) NITROARGININE METHYL ESTER; NORTRIPTYLINE; PIRENZEPINE; SEROTONIN UPTAKE INHIBITOR; SUBSTANCE P; TETRODOTOXIN; TRAZADONE; TRICYCLIC ANTIDEPRESSANT AGENT; TROPICAMIDE; UNCLASSIFIED DRUG;

ACETYLCHOLINE RELEASE; ANIMAL TISSUE; ARTICLE; CHOLINERGIC NERVE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ELECTROSTIMULATION; GUINEA PIG; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTILITY; STOMACH ANTRUM; STOMACH FUNDUS; STOMACH MUSCLE;

ACETYLCHOLINE; ADRENERGIC ALPHA-AGONISTS; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CLONIDINE; ELECTRIC STIMULATION; GASTROINTESTINAL MOTILITY; GUINEA PIGS; MUSCLE CONTRACTION; MUSCLE, SMOOTH; ORGAN CULTURE TECHNIQUES; STOMACH; SUBSTANCE P;

EID: 2342453771     PISSN: 13501925     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2004.00515.x     Document Type: Article

References (38)

1. Fisher RS, Parkman HP. Management of nonulcer dyspepsia. N Engl J Med 1998; 339: 1376-81.
2. Thumshirn M, Cho M-G, Zinsmeister AR et al. Modulation of gastric sensory and motor functions by nitrergic and alpha-2 adrenergic agents in humans. Gastroenterology 1999; 116: 573-85.
3. Gullikson GW, Virina MA, Loeffler R et al. Alpha-2-adrenergic model of gastroparesis. Am J Physiol 1991; 261: G426-32.
4. Qian LW, Peters LJ, Chen JDZ. Clonidine inhibits postprandial response of antral myoelectrical activity. Dig Dis Sci 2001; 46: 626-31.
5. Clouse RE. Antidepressants for functional gastrointestinal syndromes. Dig Dis Sci 1994; 39: 2352-63.
6. Jackson JL, O'Malley PG, Tomkins G et al. Treatment of functional gastrointestinal disorders with antidepressant medications: A meta-analysis. Am J Med 2000; 108: 65-72.
7. Bridges JW, Dent JG, Johnson P. The effects of some pharmacologically active amines on the rate of gastric emptying in rats. Life Sci 1976; 18: 97-108.
8. Grider JR, Foxx-Orenstein AE, Jin JG. 5-Hydroxytryptamine-4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine. Gastroenterology 1998; 115: 370-80.
9. Parkman HP, Pagano AP, Ryan JP. Subtypes of muscarinic receptors regulating gallbladder cholinergic contractions. Am J Physiol 1999; 276: G1243-50.
10. Evans RG, Anderson WP. Renal effects of infusion of rilmenidine and guanzbenz in conscious dogs: contribution of peripheral and central nervous system alpha-2-adrenoceptors. Br J Pharmacol 1995; 116: 1557-70.
11. 2- adrenoceptor agonists and antagonists on circling behavior in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway. J Pharmacol Exp Therap 1999; 288: 798-804.
12. Del Tacca M, Soldani G, Selli M, Crema A. Action of catecholamines on release of acetylcholine from human taenia coll. Eur J Pharmacol 1970; 9: 80-84.
13. Suprenant A, North RA. Mechanism of synaptic inhibition by noradrenaline acting at a2-adrenoceptors. Proc R Soc Lond 1988; 234: 85-114.
14. 2-adrenoceptors or imidazoline receptors? Naunyn-Schmiedeberg's Arch Pharmacol 1998; 357: 682-91.
15. Arimitsu M, Mitsui-Saito M, Sato K, Ozaki H, Koga Y, Karaki H. Mechanism of relaxant effect of clonidine in isolated bovine tracheal smooth muscle. J Pharmacol Exp Ther 1998; 286: 681-7.
16. Rosa-E-Silva L, Troncon LES, Oliveira RB et al. Treatment of diabetic gastroparesis with oral clonidine. Aliment Pharmacol Ther 1995; 9: 179-83.
17. Wittmann T, Kiss I, Izbeki F et al. Improvement of gastric emptying in patients with diabetic gastroparesis by moxonidine. Gastroenterology 2003; 124: A222 (abstract).
18. Loldrup D, Langemark M, Hansen HJ et al. Clomipramine and mianserin in chronic idiopathic pain syndrome: a placebo controlled study. Psychopharmacology 1989; 99: 1-7.
19. Mertz H, Fass R, Kodner A et al. Effect if amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia. Am J Gastroenterol 1998; 93: 160-5.
20. Prakash C, Lustman PJ, Freedland KE et al. Tricyclic antidepressants for functional nausea and vomiting: Clinical outcome in 37 patients. Dig Dis Sci 1998; 43: 1951-6.
21. Xxxx X, Xxxxx X. Physicians Desk Reference (PDR). 55th edn. Montvale, NJ: Medical Economics Company Inc., 2001.
22. Bielefeldt K, Ozaki N, Whiteis C, Gebhart GF. Amitriptyline inhibits voltage-sensitive sodium currents in rat gastric sensory neurons. Dig Dis Sci 2002; 47: 959-66.
23. Kwok YH, Mitchelson F. The effect of amitriptyline, mianserin, and viloxazime at pre- and post-junction of muscarinic receptors in guinea pig ileal longitudinal muscle. Can J Physiol Pharmacol 1982; 60: 193-200.
24. Bekpinar S, Oner P, Eryurek FG. Comparative effects of chronic administration of some psychotropic drugs on rat brain cortex acetylcholinesterase activity. Prog Neuro- Psychopharmacol Biol Psychiatry 1994; 18: 555-62.
25. Majocha R, Baldessarini RJ. Tolerance to an anticholinergic agent is paralleled by increased binding to muscarinic receptors in rat brain and increased behavioral response to a centrally active cholinomimetic. Life Sci 1984; 35: 2247-55.
26. McKinney M, Lee NH, Anderson DJ, Vella-Rountree L, El-Fakahany EE. Non-selectivity of amitriptyline for subtypes of brain muscarinic receptors demonstrated in binding and functional assays. Eur J Pharmacol 1988; 157: 51-60.
27. Ehlert FJ, Delen FM, Yun SH, Liem HA. The interaction of amitriptyline, doxepin, imipramine and their N-methyl quaternary ammonium derivatives with subtypes of muscarinic receptors in brain and heart. J Pharmacol Exp Ther 1990; 253: 13-19.
28. Stanton T, Bolden-Watson C, Cusack B, Richelson E. Antagonism of the five cloned human muscarinic cholinergic receptors expressed in CHO-K1 cells by antidepressants and antihistamines. Biochem Pharmacol 1993; 45: 2352-4.
29. Choi A, Mitchelson F. Variation in the affinity of amitriptyline for muscarinic receptor subtypes. Pharmacology 1994; 48: 293-300.
30. Nomura S, Zorn SH, Enna SJ. Selective interaction of tricyclic antidepressants with a subclass of rat brain cholinergic muscarinic receptors. Life Sci 1987; 40: 1751-6.
31. Sugrue MF. Do antidepressants possess a common mech anism of action? Biochem Pharmacol 1983; 32: 1811-7.
32. Atkinson J, Ladinsky H. A quantitative study of the anticholinergic action of several tricyclic antidepressants of the rat isolated fundal strip. Br J Pharmacol 1972; 45: 519-24.
33. Kachur JF, Allbee WE, Gaginella TS. Antihistaminic and antimuscarinic effects of amitriptyline on guinea pig ileal electrolyte transport and muscle contractility in vitro. J Pharmacol Exp Ther 1988; 245: 455-9.
34. Snyder SH, Yamamura HI. Antidepressants and the muscarinic acetylcholine receptor. Arch Gen Psychiatry 1977; 34: 236-9.
35. Shein K, Smith SE. Structure-activity relationships for anticholinoceptor action of tricyclic antidepressants. Br J Pharmacol 1978; 62: 567-71.
36. Richelson E, Nelson A. Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro. J Pharmacol Exp Ther 1984; 230: 94-102.
37. Parkman HP, Knight LC, Brown KL, Trate DM, Maurer AH, Fisher RS. Cholinergic effects on human gastric motility. Gut 1999; 45: 346-54.
38. Camilleri M, Brown ML, Malagelada J-R. Relationship between impaired gastric emptying and abnormal gastrointestinal motility. Gastroenterology 1986; 91: 94-99.